Eir Partners has announced a growth investment in Porter, a healthcare technology platform focused on enhancing care coordination and outcomes for patients across the United States.

Target Information

Porter, a pioneering platform in healthcare technology, specializes in connecting plan members with essential resources, services, products, and educational tools to enhance their home care experience. Under the leadership of John Criswell, a seasoned entrepreneur in healthcare technology, Porter addresses the complexities of the healthcare system that often hinder quality care for patients and plan members. Criswell's vision for Porter is to simplify these challenges through innovative technology solutions.

Headquartered in Baltimore, Porter stands out as the sole care coordination program focused on quality and risk adjustment. Utilizing advanced technology and AI, the platform enhances care coordination, removes barriers to follow-up treatments, and ultimately improves patient outcomes while ensuring compliance with risk adjustment programs. Porter's services are available nationwide, catering to members from diverse backgrounds with varying health conditions.

Industry Overview

The healthcare technology sector in the United States is rapidly evolving, driven by the growing demand for innovative solutions that enhance patient care and streamline healthcare processes. As healthcare costs continue to rise and

View Source

Similar Deals

New Mountain Capital Smarter Technologies

2025

Growth Equity & Expansion Capital Healthcare Facilities & Services (NEC) United States of America
Advantage Capital Gravity Diagnostics

2025

Growth Equity & Expansion Capital Medical & Diagnostic Laboratories United States of America
Ampersand Capital Partners Lexington Medical

2025

Growth Equity & Expansion Capital Medical Devices & Implants United States of America
Ampersand Capital Partners Gannet BioChem

2025

Growth Equity & Expansion Capital Biopharmaceuticals United States of America
WestView Capital Partners PharmaLink

2025

Growth Equity & Expansion Capital Pharmaceuticals (NEC) United States of America
General Atlantic U.S. Urology Partners

2025

Growth Equity & Expansion Capital Hospitals, Clinics & Primary Care Services United States of America

Eir Partners

invested in

Porter

in 2025

in a Growth Equity & Expansion Capital deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert